-
Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
(PA-18-682)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional)
(PA-18-687)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional)
(PA-18-688)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)
(PAR-18-681)
National Cancer Institute
Application Receipt Date(s): April 11, 2018; October 10, 2018; April 11, 2019, October 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
(PAR-18-683)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 4, 2018; October 2, 2018; June 4, 2019; October 2, 2019; June 4, 2020; October 2, 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
(PAR-18-684)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): June 4, 2018; October 2, 2018; June 4, 2019; October 2, 2019; June 4, 2020; October 2, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
(PAR-18-685)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): April 30, 2018 then Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
(PAR-18-686)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): April 30, 2018 then Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional)
(PAR-18-689)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional)
(PAR-18-690)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Innovative Therapies and Tools for Screenable Disorders (R21 Clinical Trial Optional)
(PAR-18-691)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 Clinical Trial Required)
(PAR-18-692)
Office of the Director, NIH
National Institute on Aging
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Center for Complementary and Integrative Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): May 1, 2018 and April 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition : HIV/AIDS-related Non-Human Primate Animal Research Facilities Restoration Program in the Aftermath of Hurricane Maria (C06 Clinical Trial Not Allowed)
(PAR-18-693)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): April 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress (R24 Clinical Trial Optional)
(PAR-18-694)
Office of the Director, NIH
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): October 29, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
(RFA-EY-18-001)
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): May 1, 2018, November 27, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Reproductive Scientist Development Program (RSDP) (K12 Clinical Trial Not Allowed)
(RFA-HD-18-103)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): May 2, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional)
(RFA-NS-18-025)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): May 8, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.